benzimidazole has been researched along with Cystic Echinococcosis in 12 studies
1H-benzimidazole : The 1H-tautomer of benzimidazole.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Hydatidosis (cystic echinococcosis, CE) constitutes a serious public health problem worldwide." | 6.42 | Benzimidazole treatment of cystic echinococcosis. ( El-On, J, 2003) |
| "At the end of therapy, 74." | 2.69 | Long-term evaluation of patients with hydatidosis treated with benzimidazole carbamates. ( Di Vico, B; Franchi, C; Teggi, A, 1999) |
| "The following keywords were used: HD, hydatid cyst, cystic echinococcosis, alveolar echinococcosis, abdominal HD, thoracic HD, parietal complication, cutaneous fistulization, cystocutaneous fistulization, cutaneous involvement, external rupture, external fistulization, subcutaneous involvement, and subcutaneous abscess." | 2.58 | Parietal complication of the hydatid disease: Comprehensive literature review. ( Akbulut, S, 2018) |
| "Albendazole chemotherapy was found to be the primary pharmacological treatment to consider in the medical management of CE." | 2.58 | Medical treatment of cystic echinococcosis: systematic review and meta-analysis. ( Alonso-Sardón, M; Belhassen-García, M; Burguillo, FJ; Carpio-Pérez, A; Cordero, M; Lopez-Bernus, A; Muñoz Bellido, JL; Muro, A; Pardo-Lledias, J; Romero-Alegría, Á; Velasco-Tirado, V, 2018) |
| "Clinical features of hepatic hydatid cyst are mainly right upper quadrant pain, feeling of lump and enlarged tender liver." | 2.43 | Management of echinococcosis. ( Joshi, A; Nepalia, S; Sharma, SS; Shende, A, 2006) |
| "Hydatidosis (cystic echinococcosis, CE) constitutes a serious public health problem worldwide." | 2.42 | Benzimidazole treatment of cystic echinococcosis. ( El-On, J, 2003) |
| "Extra-hepatic recurrence occurred in 1 case (lung) after R0 resection." | 1.42 | Outcomes After Liver Resection for Hepatic Alveolar Echinococcosis: A Single-Center Cohort Study. ( Demartines, N; Gillet, M; Halkic, N; Joliat, GR; Melloul, E; Petermann, D; Uldry, E, 2015) |
| "In conclusion, primary disease recurrence is not rare after LT for AE." | 1.30 | Primary disease recurrence after liver transplantation for alveolar echinococcosis: long-term evaluation in 15 patients. ( Bartholomot, B; Becker, MC; Beurton, I; Bresson-Hadni, S; Heyd, B; Hrusovsky, S; Koch, S; Lenys, D; Mantion, GA; Miguet, JP; Minello, A; Vanlemmens, C; Vuitton, DA, 1999) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (16.67) | 18.2507 |
| 2000's | 3 (25.00) | 29.6817 |
| 2010's | 5 (41.67) | 24.3611 |
| 2020's | 2 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| Deibel, A | 1 |
| Stocker, D | 1 |
| Meyer Zu Schwabedissen, C | 1 |
| Husmann, L | 1 |
| Kronenberg, PA | 1 |
| Grimm, F | 2 |
| Deplazes, P | 2 |
| Reiner, CS | 1 |
| Müllhaupt, B | 2 |
| Kamiyama, T | 1 |
| Siles-Lucas, M | 1 |
| Casulli, A | 1 |
| Cirilli, R | 1 |
| Carmena, D | 1 |
| Akbulut, S | 1 |
| Velasco-Tirado, V | 1 |
| Alonso-Sardón, M | 1 |
| Lopez-Bernus, A | 1 |
| Romero-Alegría, Á | 1 |
| Burguillo, FJ | 1 |
| Muro, A | 1 |
| Carpio-Pérez, A | 1 |
| Muñoz Bellido, JL | 1 |
| Pardo-Lledias, J | 1 |
| Cordero, M | 1 |
| Belhassen-García, M | 1 |
| Joliat, GR | 1 |
| Melloul, E | 1 |
| Petermann, D | 1 |
| Demartines, N | 1 |
| Gillet, M | 1 |
| Uldry, E | 1 |
| Halkic, N | 1 |
| Ammann, RW | 1 |
| Stumpe, KD | 1 |
| Huber, S | 1 |
| Bertogg, K | 1 |
| Fischer, DR | 1 |
| El-On, J | 1 |
| Daniel-Mwuambete, K | 1 |
| Ponce-Gordo, F | 1 |
| Torrado, J | 1 |
| Torrado, S | 1 |
| Cuesta-Bandera, C | 1 |
| Nepalia, S | 1 |
| Joshi, A | 1 |
| Shende, A | 1 |
| Sharma, SS | 1 |
| Franchi, C | 1 |
| Di Vico, B | 1 |
| Teggi, A | 1 |
| Bresson-Hadni, S | 1 |
| Koch, S | 1 |
| Beurton, I | 1 |
| Vuitton, DA | 1 |
| Bartholomot, B | 1 |
| Hrusovsky, S | 1 |
| Heyd, B | 1 |
| Lenys, D | 1 |
| Minello, A | 1 |
| Becker, MC | 1 |
| Vanlemmens, C | 1 |
| Mantion, GA | 1 |
| Miguet, JP | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Analysis of the Potentially Parasitocidal Effect of a Long Term Chemotherapy With Benzimidazoles in Patients With Inoperable Alveolar Echinococcosis Using PET-CT and EmII/3-10 Serology[NCT00658294] | 34 participants (Actual) | Observational | 2008-01-31 | Completed | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
5 reviews available for benzimidazole and Cystic Echinococcosis
| Article | Year |
|---|---|
Recent advances in surgical strategies for alveolar echinococcosis of the liver.
Topics: Albendazole; Anthelmintics; Benzimidazoles; Cyclosporine; Echinococcosis; Echinococcosis, Hepatic; H | 2020 |
Parietal complication of the hydatid disease: Comprehensive literature review.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Animals; Anthelmintics; Benzimidazoles; Child; Diagnosis | 2018 |
Medical treatment of cystic echinococcosis: systematic review and meta-analysis.
Topics: Albendazole; Anthelmintics; Benzimidazoles; Databases, Factual; Drug Therapy, Combination; Echinococ | 2018 |
Benzimidazole treatment of cystic echinococcosis.
Topics: Albendazole; Animals; Antibody Formation; Benzimidazoles; Drug Resistance; Drug Therapy, Combination | 2003 |
Management of echinococcosis.
Topics: Animal Husbandry; Animals; Anthelmintics; Benzimidazoles; Disease Vectors; Dogs; Echinococcosis; Hum | 2006 |
1 trial available for benzimidazole and Cystic Echinococcosis
| Article | Year |
|---|---|
Long-term evaluation of patients with hydatidosis treated with benzimidazole carbamates.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Albendazole; Animals; Anthelmintics; Benzimidazoles; Car | 1999 |
6 other studies available for benzimidazole and Cystic Echinococcosis
| Article | Year |
|---|---|
Evaluation of a structured treatment discontinuation in patients with inoperable alveolar echinococcosis on long-term benzimidazole therapy: A retrospective cohort study.
Topics: Adult; Aged; Anthelmintics; Antibodies, Helminth; Benzimidazoles; Cohort Studies; Echinococcosis; Fe | 2022 |
Progress in the pharmacological treatment of human cystic and alveolar echinococcosis: Compounds and therapeutic targets.
Topics: Albendazole; Animals; Anthelmintics; Benzimidazoles; Echinococcosis; Echinococcus multilocularis; Hu | 2018 |
Outcomes After Liver Resection for Hepatic Alveolar Echinococcosis: A Single-Center Cohort Study.
Topics: Aged; Anthelmintics; Benzimidazoles; Chemotherapy, Adjuvant; Disease Progression; Echinococcosis; Ec | 2015 |
Outcome after Discontinuing Long-Term Benzimidazole Treatment in 11 Patients with Non-resectable Alveolar Echinococcosis with Negative FDG-PET/CT and Anti-EmII/3-10 Serology.
Topics: Adult; Aged; Anthelmintics; Antibodies, Helminth; Benzimidazoles; Drug Monitoring; Echinococcosis; E | 2015 |
Effect of two formulations of benzimidazole carbamates on the viability of cysts of Echinococcus granulosus in vivo.
Topics: Albendazole; Animals; Anthelmintics; Benzimidazoles; Biological Availability; Dose-Response Relation | 2003 |
Primary disease recurrence after liver transplantation for alveolar echinococcosis: long-term evaluation in 15 patients.
Topics: Adult; Aged; Anthelmintics; Benzimidazoles; Brain; Echinococcosis; Echinococcosis, Hepatic; Echinoco | 1999 |